Related Experiment Video

Updated: Aug 29, 2026

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
10:52

Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis

Published on: December 17, 2010

Macroprolactinemia: the consequences of a laboratory pitfall

Erzsébet Toldy1, Zoltán Löcsei, István Szabolcs

  • 1Central Laboratory, Markusovszky Teaching Hospital of County Vas, Szombathely, Hungary.

Endocrine
|January 8, 2004
PubMed

Insights

Macroprolactin, a less active form of prolactin, is present in 23% of hyperprolactinemic patients. Screening for macroprolactinemia is recommended to prevent misdiagnosis and guide appropriate treatment.

Area of Science:

  • Endocrinology
  • Clinical Chemistry

Background:

  • Hyperprolactinemia is a common endocrine disorder.
  • Macroprolactin is a complex of prolactin with antibodies, exhibiting reduced bioactivity.
  • Distinguishing macroprolactinemia from true hyperprolactinemia is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence of macroprolactinemia in patients with elevated prolactin levels.
  • To investigate the clinical characteristics associated with macroprolactinemia.
  • To assess the diagnostic implications of macroprolactin in hyperprolactinemic individuals.

Main Methods:

  • Measurement of serum prolactin levels before and after polyethylene glycol (PEG) precipitation.
  • Analysis of 306 hyperprolactinemic patients with prolactin values >700 mIU/L.
  • Correlation of macroprolactinemia presence with patient demographics and clinical signs.

Main Results:

  • Macroprolactinemia was identified in 23% of the studied hyperprolactinemic patients.
  • The prevalence of macroprolactinemia increased with age in women.
  • Clinical signs of hyperprolactinemia were less frequent in patients with macroprolactinemia compared to true hyperprolactinemia.

Conclusions:

  • Macroprolactinemia is a common finding in patients with elevated prolactin levels.
  • Routine screening for macroprolactinemia in patients with prolactin >700 mIU/L is advisable.
  • Identification of macroprolactinemia can prevent misdiagnosis and unnecessary treatments for hyperprolactinemia.

More Related Videos

Induction of Experimental Autoimmune Hypophysitis in SJL Mice10:38

Induction of Experimental Autoimmune Hypophysitis in SJL Mice

Published on: December 17, 2010

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models12:57

X-Ray Visualization of Intraductal Ethanol-Based Ablative Treatment for Prevention of Breast Cancer in Rat Models

Published on: December 9, 2022

Related Concept Videos

Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...